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Abstract
The faithful expression of genes requires that cellular machinery select substrates with high
specificity at each step in gene expression. High specificity is particularly important at the stage of
nuclear pre-mRNA splicing, during which the spliceosome selects splice sites and excises
intervening introns. With low specificity, the usage of alternative sites would yield insertions,
deletions and frame shifts in messenger RNA. Recently, biochemical, genetic and genome-wide
approaches have significantly advanced our understanding of splicing fidelity. In particular, we
have learned that DExD/H-box ATPases play a general role in rejecting and discarding suboptimal
substrates and that these factors serve as a paradigm for proofreading NTPases in other systems.
Recent advances have also defined fundamental questions for future investigations.
Establishing specificity in pre-mRNA splicing
To maximize the fidelity in the inheritance and expression of genetic information, a cell
minimizes errors. In DNA replication, errors have lasting consequences; mistakes are
consequently reduced to a frequency of less than one in a billion [1]. In transcription and
translation even transient errors present risks to the cell; mistakes are consequently reduced
to roughly one in ten thousand [2, 3]. Similarly, in the removal of introns from primary
nuclear transcripts, mistakes are minimized to prevent deleterious alterations to the message
during the two catalytic steps in splicing: 5' splice site cleavage and exon ligation (Box 1).
Given the dominance of introns over exons in eukaryotic genes, establishing fidelity in this
process of pre-mRNA splicing is critical. Indeed, recent estimates of the error rate for
splicing ranges from one in one hundred to one in one hundred thousand [4–6]. Fidelity
mechanisms in splicing were first discovered nearly twenty years ago [7], but our
understanding of fidelity in splicing has lagged behind that of DNA replication, transcription
and translation. Nevertheless, our understanding of splicing fidelity mechanisms,
particularly kinetic proofreading, has deepened considerably in recent years primarily
through studies in the genetically tractable model organism Saccaromyces cerevisiae. In a
short time, we have gained insights into the mechanisms for rejecting and discarding
suboptimal substrates and the generality of these mechanisms across diverse cellular
processes. In this review, we focus on these advances, with an emphasis on the general role
of DExD/H-box ATPases in fidelity.
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DExD/H-box ATPases Antagonize Splicing of Suboptimal Substrates
To rationalize how specificity could be established in translation, Hopfield and Ninio
proposed a model nearly forty years ago, termed kinetic proofreading [8, 9]. This general
model has been verified for translation and functionally validated in other systems [1–3, 10,
11] including splicing [7, 12–15], although in splicing, kinetic proofreading manifests in a
unique and important way.
A central feature of kinetically proofread pathways is a branch in the pathway that competes
with a productive step and specifically antagonizes suboptimal substrates [8, 9, 16, 17].
Importantly, a kinetically competing branch can affect the efficiency of a process at any
step, independent of whether the competing, on-pathway step is rate-limiting. This concept
was recently nicely illustrated for alternative splicing [18]. A role for a splicing factor in
establishing a proofreading branch was first implicated by a genetic screen in the yeast S.
cerevisiae, which revealed that the splicing factor Prp16 preferentially represses suboptimal
substrates that have branch sites that deviate from the consensus [7, 19] (Box 1, Figure I).
The DEAH-box ATPase Prp16 is one of eight spliceosomal ATPases that are conserved
across eukaryota and belong to the ubiquitous SF2 superfamily of ATPases, which includes
the DExD/H-box families of RNA helicases (Box 2). Recent genetic studies have firmly
established the importance of spliceosomal DExD/H-box ATPases in antagonizing
suboptimal splicing substrates in vivo (Figure 1). First, Prp5, a DEAD-box ATPase that is
conserved from budding yeast to humans, was shown to promote branch site fidelity by
interrogating U2 snRNA recognition of the branch site [12, 13]. Further, during exon
ligation the conserved DEAH-box ATPase Prp22 antagonizes primarily suboptimal 3' splice
sites but also suboptimal 5' splice sites and branch sites [14], underscoring the multiple
stages at which a substrate feature is inspected. Indeed, in mammals the 3' splice site is also
proofread at the earliest stages of intron recognition [20, 21].
The fidelity functions of each of these factors require DExD/H-box ATPase function.
Mutant alleles of PRP5, PRP16 or PRP22 that compromise ATPase activity permit increased
utilization of suboptimal substrates in vivo [7, 12, 14]. Further, prp5 alleles with a range of
ATPase activity deficiency show proportional deficiencies in the antagonization of
suboptimal branch sites, demonstrating the importance of the rate of rejection in kinetic
proofreading [12]. In addition, mutations that do not compromise ATPase activity but
compromise RNA unwinding activity also compromise fidelity in vitro [14], highlighting
the role of RNP rearrangements in proofreading.
Biochemical studies of DExD/H-box ATPases have confirmed the general roles for these
factors in splicing fidelity and have provided further insight into their mechanisms. Prp16
and Prp22, in particular, have been shown to proofread the chemical steps of splicing by
parallel mechanisms [14, 15]. Recent genetic studies suggested that Prp16 proofreads by
destabilizing the 5' splice site cleavage conformation of the spliceosome, either before or
after 5' splice site cleavage [22, 23]. A subsequent in vitro study established that Prp16
proofreads by competing directly with 5' splice site cleavage [15]. Similarly, in vitro studies
have established that Prp22 proofreads by competing directly with exon ligation [14].
Genetic studies have revealed that suboptimal substrates are also disfavored because the
spliceosome sequesters the substrate away from the relevant catalytic conformation in favor
of competing conformations [22, 24–26] (Box 3). Prp16- and Prp22-mediated rejection
likely plays a role in driving this sequestration. Additionally, Prp16- and Prp22-mediated
rejection can lead to discard of rejected substrates (see below). The similarity between the
mechanisms of Prp16-dependent proofreading at 5' splice site cleavage and Prp22-dependent
proofreading at exon ligation suggests a general role for DExD/H-box ATPases in
proofreading by competing with productive events.
Semlow and Jonathan P. Staley Page 2
Trends Biochem Sci. Author manuscript; available in PMC 2013 August 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Proofreading DExD/H-box ATPases also promote optimal substrates
Over twenty years ago Prp16 was found not only to antagonize suboptimal branch site
substrates but also to promote optimal substrates by enabling spliceosome rearrangements
after 5' splice site cleavage [27]. The generality of such a dual role has recently been
established (Figure 1). Prp5 not only antagonizes substrates with suboptimal branch sites but
also promotes stable binding of U2 snRNP to substrates with optimal branch sites [13, 28].
Further, Prp22 not only antagonizes suboptimal substrates but also promotes optimal
substrates by catalyzing release of the mRNA product [29, 30].
Although proofreading DExD/H-box ATPases both antagonize and promote substrates,
these opposing activities appear highly related. Recent genetic data indicate that Prp5 both
promotes and antagonizes substrates by destabilizing the stem of the U2 branchpoint-
interacting stem loop (BSL); the loop is thought to allow sampling of candidate branch sites
through base pairing [13]. Therefore, mutations that destabilize this stem suppress a prp5
mutant, relieving stalled optimal substrates, but these same mutations also enhance Prp5-
mediated rejection of suboptimal substrates.
Similarly, genetic experiments indicate that Prp16 both rejects suboptimal substrates and
promotes optimal substrates by antagonizing features important for 5' splice site cleavage,
including Prp8, Isy1, U2/U6 helix I and U2 stem IIc. Mutations in these features can
suppress a prp16 mutant, relieving stalled optimal substrates, but these same mutations also
enhance Prp16-mediated rejection of a suboptimal substrate [22, 23, 25, 26]. Furthermore,
biochemical studies have revealed that Prp16 promotes an optimal substrate after 5' splice
site cleavage by allowing the release of Cwc25 and Yju2. This study also suggests that
Prp16 likely antagonizes a suboptimal substrate before 5' splice site cleavage by allowing
the release of Cwc25, which interacts only weakly with mutated branch sites [31].
Finally, Prp22 both rejects suboptimal substrates and promotes optimal substrates by
antagonizing components that are important for anchoring exons to the spliceosome and
juxtaposing splice sites, such as Prp8 and the U5 loop. Mutations thought to destabilize
these interactions suppress a cold-sensitive prp22 mutant by relieving stalled optimal
substrates, while also increasing Prp22-mediated rejection of suboptimal substrates [24, 32].
These two Prp22 roles could be mediated by a single mechanism: translocation from the
downstream exon in the 3' to 5' direction, a polarity that is characteristic of the DEAH-box
family [33–35]. Before exon ligation translocation would dissociate the 3' splice site from
the catalytic core of the spliceosome; whereas after exon ligation translocation would
dissociate the 5' exon and consequently mRNA [14]. Indeed, a Prp22 ATPase mutant
engages the 5' end of the 3' exon, consistent with a pre-translocation state [36]; when exon
ligation is impaired, Prp22 crosslinks just upstream of the 3' splice site [37], consistent with
a post-translocation rejected state.
Consistent with highly related dual activities, recent biochemical studies establish that the
difference in outcome depends simply on the timing of DExD/H-box ATPase activity
(Figure 1). Prp16 antagonizes suboptimal substrates just before 5' splice site cleavage and
promotes optimal substrates just after this reaction [15, 27, 31]. Equivalently, Prp22
antagonizes suboptimal substrates just before exon ligation and promotes optimal substrates
just after exon ligation [14, 29, 30, 36]. Genetic studies similarly imply that Prp5
antagonizes suboptimal substrates just before an undefined transition in branch site
recognition and that Prp5 promotes optimal substrates just after this transition [12, 13, 28].
Thus, any DExD/H-box ATPase may proofread a biochemical step by simply acting before,
rather than after, the proofread step.
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Models for the kinetic basis of substrate specificity
A critical unanswered question is how DExD/H-box ATPases promote substrate specificity.
In two non-mutually exclusive models, DExD/H-box ATPases function as timers and/or as
sensors of authenticity (Figure 2). In either model, the rate of each ATPase must be tuned to
the rate of the proofread step.
In the timer model, the DExD/H-box ATPase restricts the window of time allotted for a
particular splicing event (Figure 2, middle). If a substrate proceeds through the proofread
step faster than the DExD/H-box ATPase acts, then the ATPase would function after the
step and promote a conformational change that is productive. Conversely, if the substrate
proceeds through the proofread step slower than the DExD/H-box ATPase acts, then the
ATPase would function before the step and promote a conformational change that is
antagonistic; for example, Prp5 would antagonize substrates if they were slow to fully
engage U2 snRNA, Prp16 would antagonize substrates if they were slow to undergo 5'
splice site cleavage and Prp22 would antagonize substrates if they were slow to undergo
exon ligation. This model is attractive because all three of these DExD/H-box ATPases
discriminate against substrates having intronic sequences that deviate from the consensus
and likely delay assembly and/or catalysis [7, 12–14]. Further, this mode of kinetic
proofreading parallels modes observed in other systems, including transcription and
translation [2, 3].
Recent results provide evidence for the timer model in splicing. When a U6 metal-ligand
interaction that is subject to Prp16-mediated proofreading is disrupted, spliceosomes
undergo 5' splice site cleavage an order of magnitude more slowly than when the metal-
ligand interaction is intact, as determined in the absence of Prp16-mediated proofreading
[15]. However, it remains to be determined whether the rate of Prp16-dependent rejection is
tuned appropriately to discriminate between such rates. Additionally, it remains to be proven
that suboptimal substrates undergo 5' splice site cleavage more slowly than an optimal
substrate.
In the alternative sensor model, a DExD/H-box ATPase rejects a suboptimal substrate more
quickly than an optimal substrate (Figure 2, right). Such differential rejection could be
established by at least two mechanisms. In one mechanism, differential rejection could
reflect differences in the stability of substrate-spliceosome interactions, as in kinetic
proofreading in translation [3]. Indeed, several DExD/H-box ATPases destabilize less stable
substrates faster than stable ones (Box 2). In a second mechanism, differential rejection is
established by regulation of the proofreading DExD/H-box ATPase. In support of this
model, several members of this family are positively or negatively regulated (Box 2). Note
that DEAH-box protein Prp43 discards optimal and suboptimal substrates with equal
probability (see below), so the contribution of Prp43 to fidelity likely depends on differences
in forward rates [38].
Spliceosomal proofreading: unique features
In kinetic proofreading, as originally proposed by Hopfield and Ninio, NTP hydrolysis
drives an irreversible step that introduces a new, high energy intermediate that must partition
between two kinetically competing pathways (Figure 3a–c) [1–3,8,9]. This competition
allows additional scrutiny of a substrate beyond the initial stage of enzyme binding. Splicing
also employs energy for kinetic proofreading but utilizes energy in a distinct manner (Figure
3d,e). Specifically, DExD/H-box mediated ATP hydrolysis drives the rejection branch to
accelerate this route relative to the competing productive pathway [16, 17, 39]. This unique
framework for spliceosomal proofreading by DExD/H-box ATPases has significant
implications.
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First, the acceleration of rejection allows for a more rapid proofread step. Second, kinetic
proofreading is not obligatory for splicing, in contrast to replication, transcription and
translation, for which kinetic proofreading is obligatory due to the on-pathway requirement
for NTP hydrolysis (Figure 3). For example, a GTPase mutation in EF-Tu increases the
fidelity of translation by allowing more time for dissociation of ternary complexes prior to
on-pathway GTP hydrolysis [40]. By contrast, ATPase mutations in PRP5, PRP16 or PRP22
decrease the fidelity of splicing by allowing more time for on-pathway events for suboptimal
splicing substrates [7, 12–15]. Moreover, a rejection branch can be entirely eliminated in
vitro: ATP depletion eliminates both the Prp16-dependent and Prp22-dependent
proofreading branches, thereby allowing 5' splice site cleavage of suboptimal splice sites
and exon ligation of suboptimal substrates, respectively [14,15].
An important implication of non-obligatory proofreading is that maximal discrimination
requires that the proofreading DExD/H-box protein bind the spliceosome and ATP before
the proofread step. In principle, the DExD/H-box ATPase can only bind before the
proofread step for slowly-reacting suboptimal substrates, although in that context NTPase
activity cannot be regulated to enhance specificity. Alternatively, the binding of the DExD/
H-box ATPase can be required for the efficiency of the proofread step. Indeed, Prp22 is
ATP-independently required for exon ligation, at least for introns that have a long
branchpoint to 3' splice site distance [29]. Interestingly, Prp16 is similarly ATP-
independently required for 5' splice site cleavage, at least for introns having a mutation at
the branch site [31].
Another important implication of non-obligatory proofreading is the possibility that DExD/
H-box ATPases could be regulated locally or globally to relax proofreading, allowing
utilization of alternative, suboptimal splice sites. Currently, the strongest candidate for such
regulation is telomerase RNA (TER1) from Schizosaccharomyces pombe. Remarkably,
TER1 corresponds to a 5' exon and the spliceosome functions as a 3' end processing factor
[41]. The intron immediately downstream of TER1 recruits the spliceosome, which cleaves
the 5' splice site separating TER1 from the intron. Although the intron includes a consensus
3' splice site, suggesting exon ligation can occur under some conditions, in exponentially
growing cells exon ligation is prevented and splicing is aborted, allowing biogenesis of
TER1 as a 5' exon. This release of intermediates conspicuously mimics the discard of
suboptimal substrates by Prp43, following rejection by Prp22 (discussed later). If Prp22 and
Prp43 promote TER1 biogenesis, repression of either factor could lead to upregulation of
exon ligation and downregulation of TER1. In the future, it will be important to test the role
of proofreading activities in regulating splicing.
A third distinguishing feature of spliceosomal proofreading is that all on-pathway steps in
the process are reversible. In replication and transcription, the hydrolysis of NTP that is
required for phosphodiester bond formation is irreversible. Similarly, in translation the
hydrolysis of GTP by EF-Tu that is required for accommodation of aminoacyl tRNA is
irreversible. Thus, errors at these stages cannot be corrected through reversal and instead
require nucleic acid hydrolysis or discard of aminoacyl tRNA. However, in splicing, the first
studies of single spliceosomes by total internal reflection fluorescence (TIRF) microscopy
have revealed that all detected transitions are reversible [42, 43] and a recent biochemical
study has verified that each of the two chemical steps of splicing are reversible [44]. Thus,
in the future it will be important to determine whether the spliceosome reverses the
advancement of suboptimal splice sites to allow the subsequent advancement of alternative,
optimal splice sites.
A final distinguishing feature of spliceosomal proofreading is that Prp16, Prp22 and possibly
Prp5 reject suboptimal splicing substrates in a reversible manner [14, 15], in contrast to the
Semlow and Jonathan P. Staley Page 5
Trends Biochem Sci. Author manuscript; available in PMC 2013 August 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
irreversible hydrolysis of incorrect nucleotides in nucleic acid polymerization or the
irreversible dissociation of near-cognate aminoacyl tRNA in translation. In splicing,
rejection alone is not sufficient to dissociate a substrate from the spliceosome, so a splice
site can re-engage the catalytic core and undergo splicing. This reversibility of rejection
suggests that proofreading DExD/H-box ATPases facilitate both the sampling of competing
alternative splice sites and the selection of an optimal splice site, and thereby function as
RNA chaperones.
Discard of rejected substrates
Although reversibility may allow the selection of an optimal splice site after rejection of a
suboptimal site, if an optimal site is not available then the cell degrades the substrate by one
of several pathways [45]. First, substrates can undergo turnover by nuclear nucleases that
compete with splicing [46–48]. Second, substrates can dissociate from the spliceosome,
undergo export to the cytoplasm, and then suffer turnover by cytoplasmic nucleases [49].
Alternatively, after export to the cytoplasm, rejected substrates can engage the ribosome. For
instance, rejected lariat intermediates that have been engineered to have an internal ribosome
entry site (IRES) can undergo translation [38]. Furthermore, suboptimal pre-mRNAs can
undergo translation-dependent nonsense-mediate decay (NMD) [49–53]. Short introns are
under strong selective pressure, across eukaryotes, to maintain in-frame pre-mature
termination codons, which highlights the significance of NMD in limiting the accumulation
of unspliced pre-mRNAs, [54]. While some NMD-targeted pre-mRNAs may fail to ever
engage the spliceosome, recent results indicate that suboptimal pre-mRNAs can bind the
spliceosome but then suffer rejection [15].
Genetic and biochemical studies have established that suboptimal substrates are dissociated
or discarded from the spliceosome by the DEAH-box ATPase Prp43, which is conserved
from budding yeast to humans. For optimal substrates, Prp43 promotes release of the
excised lariat intron following release of the ligated mRNA [55–58]. Mutations in Prp43 or
its cofactor Spp382/Ntr1 suppress mutations in splicing factors that compromise
spliceosome assembly, suggesting an additional role in quality control and disassembly of
stalled spliceosomes [59]. Furthermore, in vitro studies have shown that Prp43 discards pre-
mRNA rejected by Prp16, due to disruption of a critical metal-ligand interaction [15], and it
discards splicing intermediates that are stalled due to suboptimal consensus sites [38].
Prp43-dependent discard of intermediates, and possibly pre-mRNA, contributes to fidelity,
because maximal repression of a cryptic splice 3' splice site requires Prp43 [38]. However,
Prp43 also promotes discard of wild-type lariat intermediates [38, 49], indicating that Prp43-
dependent proofreading acts nonspecifically; nevertheless, Prp43 especially limits
accumulation of spliceosomes that are stalled due to a suboptimal substrate (Box 4). These
data support a model in which Prp16 and Prp22 antagonize forward progression of
suboptimal substrates, while Prp43 acts in conjunction to promote dissociation of these
stalled substrates.
Because the role of Prp43 in the discard of suboptimal substrates parallels the role of Prp43
in the release of the excised intron, Prp43 functions as a general splicing terminator.
Translation activities that function in termination similarly perform parallel roles in quality
control (Box 4). Additionally, factors that promote disassembly of the translocon docking
apparatus similarly function in a second capacity to promote specificity (discussed later).
Thus, common activities function to disassemble both canonical termination complexes and
suboptimal complexes broadly across diverse processes.
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Implications for proofreading by other NTPases within and beyond the
DExD/H-box family
Although kinetic proofreading through direct coupling of ATP hydrolysis to substrate
rejection departs significantly from canonical kinetic proofreading, this particular
manifestation of kinetic proofreading has been implicated for four different spliceosomal
DExD/H-box ATPases, thereby establishing the generality of this mechanism. Thus, a wide
range of DExD/H-box ATPases may promote fidelity in disparate RNA-dependent
processes. Where a DExD/H-box ATPase functions productively at a particular step in a
process, such a DExD/H-box ATPase could also compete kinetically with the preceding step
to proofread this step (Figure 3d).
Importantly, this manifestation of kinetic proofreading need not to be restricted to the
DExD/H-box class of NTPases. Indeed, proofreading of splicing by DExD/H-box ATPases
is functionally indistinguishable from a recently discovered mechanism for proofreading of
protein translocation by GTPases (Figure 3f) [10]. In translocation, the signal recognition
particle (SRP), which includes a universally conserved GTPase, recognizes the signal
sequence of a nascent protein and co-translationally targets the protein for secretion by
binding in a GTP-dependent manner to the SRP receptor (SR), which also includes a
GTPase. Binding is followed by transfer of the nascent peptide to the translocation
machinery, the translocon. Subsequently, GTP hydrolysis triggers disassembly of the SRP-
SR complex, much as, subsequent to release of ligated mRNA, ATP hydrolysis triggers
Prp43-dependent disassembly of the spliceosome.
In addition to binding optimal nascent peptides, SRP binds suboptimal peptides that do not
ultimately translocate, indicating downstream fidelity mechanisms [10]. In one mechanism,
the transfer of cargo to the translocon is challenged by a competitive GTP-dependent branch
that disassembles the SRP-SR complex. In the case of suboptimal cargo, the SRP-SR
complex hydrolyzes GTP and disassembles before releasing cargo into the translocon.
Interestingly, the rate of GTP hydrolysis with suboptimal cargo is similar to the rate without
cargo, implying that early disassembly occurs by default. Indeed, in the case of optimal
cargo, GTP hydrolysis is repressed 6- to 8-fold, thereby delaying disassembly until after
transfer of cargo to the translocon. Thus, while the regulation of proofreading DExD/H-box
ATPases remains to be investigated, the GTPase activity of the SRP-SR complex functions
analogously to the ATPase activity of spliceosomal DExD/H-box ATPase fidelity factors in
selectively rejecting suboptimal substrates within a kinetic proofreading framework. This
similarity suggests that other GTPases, as well as other ATPases, may proofread in addition
to promoting a process, especially when the NTPase normally rearranges or disassembles a
complex.
Concluding remarks
Although a general framework for kinetic proofreading was proposed nearly 40 years ago
[8, 9], in the past several years the specific manifestation of kinetic proofreading that
requires an NTP-dependent branch has emerged as a recurrent and important fidelity
mechanism. In splicing, this mechanism utilizes DExD/H-box ATPases to both reject and
discard suboptimal substrates [7, 12–15, 22, 23, 38]. In translocation, this mechanism
utilizes GTPases to reject illegitimate substrates [10]. In the future, it will be important to
consider broadly the role of such NTPases in establishing competitive branches that promote
fidelity. Recent advances have also raised a number of intriguing and important, broad and
mechanistic questions (Outstanding Questions Box). For example, is the newly-discovered
link between splicing and transcriptional pausing [60, 61] mediated by fidelity factors?
Answers to these questions will require ingenuity as well as an array of cutting edge
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strategies, ranging from single-molecule to genome-wide approaches. Without a doubt,
exciting times lie ahead, as the field addresses these questions and determines how the
spliceosome as well as other processes stay on message.
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Box 1. A working definition of splicing fidelity
The notion of fidelity, which implies the possibility of errors, can be a somewhat
muddled concept because errors in one context can be advantageous in another. For
example, in DNA replication slipped-strand mispairing, which can reversibly alter
promoters or coding regions, underlies regulation of a number of phase-like switches
between bacterial phenotypic states [62]. Also, in translation mis-acylation of non-Met
tRNAs with Met, which increases ten-fold upon oxidative stress, is thought to promote
scavenging of reactive oxygen species [63]. The concept of fidelity in splicing can be
especially muddled given splice site degeneracy and alternative splice site utilization,
which alters the pathway for the two transesterifcation reactions (Figure I). For the
purpose of this review we define splicing fidelity as the mechanisms by which the
spliceosome catalyzes intron excision to favor optimal splice sites while discriminating
against suboptimal splice sites. We define optimal splice sites as those empirically
demonstrated to splice efficiently, and suboptimal splice sites as those observed to splice
inefficiently. Frequently, optimal splice sites conform to consensus sequences for the 5'
splice site, branch site and 3' splice site, as defined by conservation across introns within
a species (Figure I). However, deviation from the splice site consensus sequence does not
necessarily render a splice site suboptimal; in some cases, non-consensus splice sites can
splice more efficiently than a corresponding consensus splice site [64]. Suboptimal splice
sites generally fall into two categories: those in which an optimal splice site is mutated so
it is no longer efficiently recognized, and the cryptic splice sites that may resemble
optimal splice sites in sequence but only efficiently compete for recognition upon
inactivation of an optimal splice site. Importantly, the definition of fidelity used in this
review may run counter to favorable gene expression. At least 15% and potentially as
much as 50% of disease phenotypes derive from point mutations that convert optimal to
suboptimal splice sites or suboptimal to optimal splice sites, resulting in exon skipping or
cryptic splicing events, respectively [65, 66]. In such cases, fidelity mechanisms may
contribute to the discrimination against suboptimal but favorable splice sites or the
selection of optimal but undesirable splice sites.
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Box 2. DExD/H-box ATPases remodel RNP complexes by distinct
mechanisms
The eight ATPases conserved in splicing include members of the DEAD-box, DEAH-
box, and Ski2-like ATPase families of the SF2 superfamily of helicases [67]. These
families are characterized by motifs that confer NTP binding and hydrolysis, RNA
binding, and RNA rearrangements [33]. Despite sharing similar architectures, the DEAD-
box family remodels RNP complexes by a mechanism that is distinct from the DEAH-
box and Ski2-like families. DEAD-box ATPases rearrange RNA duplexes through local
strand separation in which the DEAD-box protein loads, upon ATP binding, onto one
strand of a duplex, thereby inducing a local opening and allowing the remainder of the
duplex to unwind passively [68]. In contrast, DEAH-box and Ski2-like proteins act as
translocases capable of disrupting extensively base-paired helices [69]. Recent crystal
structures of the spliceosomal DEAH-box ATPase Prp43 and Ski2-like ATPase Brr2
have revealed structural similarities to the DNA helicase Hel308 [35, 70–72]. The Prp43
and Brr2 Hel308-like folds form i) a channel predicted to clamp onto single-stranded
RNA and to confer processivity and ii) a helix predicted to contact RNA and through
ratcheting, to promote unidirectional movement. Regardless of the specific mechanism,
spliceosomal DExD/H-box ATPases utilize cycles of ATP binding and hydrolysis to
disrupt RNA structures, to both promote splicing of optimal substrates and to antagonize
splicing of suboptimal substrates. DExD/H-box ATPases can be modulated by a variety
of factors including positive and negative regulators and the stability of a substrate itself.
For example, the nuclear mRNA export factor and DEAD-box ATPase Dbp5 is activated
by InsP6-Gle1, which may confer directionality to mRNA export, given the localization
of Gle1 to the cytoplasmic fibrils of the nuclear pore complex [73, 74]. Conversely, the
ATPase activity of eIF4AIII is repressed by MAGOH-Y14 upon deposition upstream of
an exon-exon junction, enabling it to stably clamp an exon-exon junction complex onto
spliced mRNA [75]. Furthermore, the DEAD-box ATPase CYT-19, which chaperones
folding of group I intron RNA, more rapidly destabilizes non-native conformations than
the more stable, native conformation [76]. Thus, through modulation of their activity,
spliceosomal DExD/H-box ATPases might enhance specificity by either preferentially
stabilizing interactions with optimal substrates and/or preferentially destabilizing
interactions with suboptimal substrates. However, it remains to be determined to what
extent these different modes of regulation are utilized by spliceosomal DExD/H-box
ATPases.
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Box 3. Equilibration between distinct spliceosomal conformations
promotes fidelity
Many different spliceosomal mutations suppress defects in splicing suboptimal
substrates, thereby compromising fidelity [7, 12–14, 22–24, 38, 59]. Curiously, many
suppressors of exon ligation defects compromise 5' splice site cleavage and vice versa,
inspiring a model in which the two catalytic spliceosomal conformations compete to
promote fidelity [22, 24] (Figure Ia). In this model, splicing intermediates that are
defective for exon ligation destabilize the exon ligation conformation and consequently
repopulate the 5' splice site cleavage conformation (Figure Ib). Similarly, pre-mRNAs
that are defective for 5' splice site cleavage destabilize the 5' splice site cleavage
conformation and instead populate an exon ligation-like conformation. In both cases,
populating the competing conformation sequesters suboptimal substrates and favors
discard rather than splicing of the substrate. In the model, exon ligation defects are
suppressed by mutations that effectively destabilize the 5' splice site cleavage
conformation, allowing efficient population of the exon ligation conformation (Figure Ic)
and vice versa [22], [24].
A distinct class of suppressors of exon ligation defects implicates a third conformation
important for fidelity [25, 26]. Such suppressors do not exacerbate 5' splice site cleavage
defects and indeed act by weakening snRNA structures absent at the 5' splice site
cleavage stage. Thus, these suppressors destabilize a unique conformation that is
intermediate between the two catalytic conformations (Figure Id). Like the catalytic
conformations, this conformation acts as a sink for suboptimal substrates and may
represent an open state of the spliceosome that normally permits substrate rearrangement.
Equilibration of spliceosomal conformations suggests that the spliceosome may
repeatedly sample and reject even an optimal 3' splice site before ultimately splicing.
Recent structural studies of RNA Polymerase II suggest an analogous model for promoter
proofreading during transcription initiation [11]. The initial transcription of a short RNA
results in a product that binds the DNA template weakly and frequently dissociates (i.e.,
suffers rejection). In this model, at a spurious promoter this abortive initiation provides
an additional opportunity for polymerase dissociation (i.e., discard) subsequent to initial
binding, whereas at a genuine promoter, which is replete with transcription factors and
sequence-specific contacts, polymerase remains bound and re-initiation is favored. Thus,
equilibration of promoter binding through abortive transcription would ensure
polymerase transits to an elongating complex only at genuine promoters. Although the
fidelity of splicing appears enhanced by equilibration of a suboptimal substrate to
alternative conformations, it remains unknown whether splicing of an optimal substrate is
also subject to equilibration.
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Box 4. Spliceosomal discard: parallels with translation termination
Prp43 functions to both discard suboptimal substrates and release the excised intron
product [15, 38, 56], suggesting that Prp43 functions in a general splicing termination
pathway. Interestingly, the ribosome also appears to use a general termination pathway in
both quality control and termination at a stop codon. The translation quality control
mechanism no-go decay (NGD) results in dissociation of ribosomal subunits and peptidyl
tRNA after ribosomal stalling due to stable mRNA secondary structure, rare codons or
ribosome decoding mutations [77, 78]. This pathway requires Dom34-Hbs1, a complex
that dissociates stalled ribosomes through a mechanism that mimics peptide release by
the eRF1-eRF3 complex. eRF1 specifically recognizes stop codons in the ribosome A
site and, stimulated by the GTPase activity of eRF3, promotes hydrolysis of peptidyl-
tRNA [79]; eIF3, aided by eIF1, eIF1A, and eIF3j, then stimulates subunit dissociation
and release of P-site tRNA and mRNA [80]. The structurally similar Dom34-Hbs1
complex [81, 82] utilizes Dom34 to recognize an empty ribosomal A site in a codon-
independent manner and to promote peptide release, as well as subunit dissociation, upon
stimulation by the GTPase activity of Hbs1 but without hydrolysis of peptidyl-tRNA
[83]. It has been proposed that Dom34-Hbs1 is restricted to stalled ribosomal complexes
due to a kinetic competition in which additional elongation cycles, including ternary
complex binding (Box 3, Figure Ib), are kinetically favored for functional ribosomes and
NGD only becomes kinetically favored when translation is stalled and Dom34-Hbs1 can
effectively compete with a ternary complex [84]. Interestingly, Cheng and colleagues
have recently shown that productive splicing factors compete with Ntr2, a Prp43
recruitment factor [85], for binding to the spliceosome at different stages in the splicing
pathway and further that binding of the productive splicing factors is favored unless
splicing is stalled (H.C. Chen et al., unpublished). Thus, the spliceosome and the
ribosome rely on common mechanisms to disassemble both canonical termination
complexes and stalled complexes, and these mechanisms appear to be regulated by
kinetic competition between productive factors and disassembly factors. Prp43 also
apparently functions to displace small nucleolar RNAs (snoRNAs) from pre-60S
ribosomal subunits during ribosomal RNA (rRNA) biogenesis, suggesting that Prp43
may act as a termination factor for small nucleolar ribonucleoprotein (snoRNP)
complexes during ribosome biogenesis as well [86, 87]. In the future, it will be
interesting to determine whether Prp43 acts in a quality control capacity to promote
dissociation of non-functional or inappropriately assembled snoRNP during rRNA
maturation.
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Outstanding Questions
The prevalence of spliceosomal DExD/H-box ATPase-dependent proofreading that has
been recently uncovered has introduced a suite of new questions that must be addressed
to comprehend how proofreading influences splicing. Chief among these questions is:
what is the kinetic basis for the observed specificity of DExD/H-box ATPase-dependent
proofreading? As discussed, DExD/H-box ATPases may function as timers tuned to
reject suboptimal substrates that progress slowly or as sensors of substrate identity that
reject suboptimal substrates at a faster rate. An explicit analysis of the rates of rejection
and the forward, proofread step will be required to determine the contributions of the
timer and sensor models to the specificity of DExD/H-box ATPase-dependent
proofreading.
Another critical question is: what are the molecular mechanisms of DExD/H-box-
mediated rejection? In no case has the direct target for rejection been defined. Although
Prp22 has been shown to promote an optimal substrate after the proofread step by
interacting directly with the substrate to effect mRNA release [36], it is unclear whether
the pathway of Prp22-dependent rejection involves a similar mechanism. Direct
molecular targets must be identified for Prp22 as well as Prp5, Prp16, and Prp43, to
understand how these DExD/H-box ATPases promote splicing fidelity.
We also need to determine whether rejection of suboptimal substrates by DExD/H-box
ATPases could represent a specific manifestation of a broader role for these factors in
promoting a search for an optimal splice site. For example, because the spliceosome can
catalyze exon ligation at multiple competing 3' splice sites, the spliceosome might readily
bind a wide range of candidate sites. Prp22 could, through rejection of suboptimal sites,
promote sampling of alternative sites and ultimately identification of an optimal 3' splice
site. Furthermore, we must determine whether DExD/H-box ATPase-dependent splice
site sampling is regulated to influence alternative splicing events as well.
In the cell, splicing is tightly coupled to transcription, raising questions concerning the
impact of co-transcriptional splicing on spliceosomal fidelity and vice versa. The
presence of a functional intron can induce RNA polymerase II to pause during
transcription [60, 61]. This pausing is eliminated by splice site mutations that are
subjected to DExD/H-box ATPase-dependent proofreading [60]. Therefore, it will be
important to determine whether RNA polymerase II pausing is sensitive to the activity of
spliceosomal fidelity factors.
Finally, it will be important to determine the breadth of the NTPase-dependent rejection
mode of kinetic proofreading across disparate cellular processes.
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Figure 1.
Functions of known proofreading DExD/H-box ATPases in the splicing pathway. During
assembly, small nuclear ribonucleoproteins (snRNPs) (small blue circles) assemble on a pre-
mRNA intron (black line) flanked by exons (yellow rectangles) in a stepwise manner.
Following engagement of pre-mRNA by U2 snRNP (a), Prp5-dependent rejection (b)
competes with branch site recognition by U2 (c) to antagonize splicing at introns with
suboptimal branch site sequences [12, 13]. After formation of optimal branch site-U2
interactions, Prp5 activity stabilizes U2 association with the substrate (d) [13, 28]. Following
addition of the U4/U6•U5 tri-snRNP, U1 and U4 are released (e), leading to formation of a
catalytically active spliceosome (large blue oval). For substrates with suboptimal branch site
sequences, Prp16-dependent rejection (f) competes with 5' splice site cleavage (g), resulting
in formation of an intermediate that can lead to Prp43-mediated discard of the pre-mRNA
substrate (h) [7, 15, 22, 23]. After 5' splice site cleavage of an optimal substrate, Prp16
promotes a transition to the exon ligation conformation of the spliceosome (i) [27]. For
suboptimal substrates, Prp22-dedpendent rejection (j) competes with exon ligation (k),
resulting in formation of an intermediate that can lead to discard of the 5' exon and lariat
intermediate (l), again mediated by Prp43 [14, 38]. After exon ligation of an optimal
substrate, Prp22 promotes release of the nascent mRNA from the spliceosome (m) [29, 30].
Following mRNA release, Prp43 promotes release of the excised intron and dissociation of
the spliceosome into its component snRNPs (n) [55–58]. The canonical splicing pathway is
indicated by heavy arrows.
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Figure 2.
Alternative manifestations of kinetic proofreading in the spliceosome. In the case of an
optimal substrate (left panel), the rate of the forward on-pathway conversion of substrate (S)
to product (P) (kF) is faster than the rate of DExD/H-box ATPase mediated rejection (kR).
Consequently, ATP hydrolysis by the proofreading DExD/H-box ATPase occurs after the
conversion and results in transition to a productive conformation (P') at rate kP. In the case
of a suboptimal substrate (middle and right panels), the rate of rejection effectively
competes with the forward rate of conversion to antagonize splicing, resulting in formation
of a rejected conformation (SR). Two non-mutually exclusive models can explain specificity
for rejection of suboptimal substrates. In proofreading at the conversion step (middle panel),
the rate of rejection may be constant for optimal and suboptimal substrates while the
conversion rate (boxed) is sufficiently reduced in the case of a suboptimal substrate such
that the rate of rejection is faster than the rate of conversion. In proofreading at the rejection
step (right panel), the rate of conversion may be constant for optimal and suboptimal
substrates while the rate of rejection (boxed) is enhanced for a suboptimal substrate relative
to an optimal substrate, similarly leading to a faster rate of rejection than rate of conversion.
Such relative enhancement of the rejection rate for a suboptimal substrate might be achieved
by stimulation of rejection by a suboptimal substrate or by repression of rejection by an
optimal substrate. The sizes of the arrows reflect the magnitude of their rates. Green arrows
represent utilization of the productive pathway; red arrows represent utilization of the
rejection pathway; black arrows represent unutilized pathways.
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Figure 3.
Distinct manifestations of kinetic proofreading across diverse biochemical pathways. (a)
Obligatory kinetic proofreading scheme employed during translation and DNA replication
[8, 9]. Unbound substrate (SU) can engage the enzyme. The initial enzyme-substrate
complex (SB) can dissociate or undergo an irreversible transition to an activated
intermediate complex (S*) through the input of energy in the form of NTP hydrolysis. From
the activated complex, conversion to a new on-pathway intermediate (P) competes with a
branch in the pathway that results in rejection of the substrate (SR). (b) Kinetic proofreading
during aminoacyl-tRNA selection on the ribosome [3]. Aminoacid-charged tRNA (green,
amino acid; orange, tRNA) binds the ribosome (purple) as part of a ternary complex with
EF-Tu and GTP (red). The initial recognition complex then undergoes irreversible GTP
hydrolysis by EF-Tu, which then dissociates. In the subsequent inspection, accommodation
of the aminoacyl-tRNA into the catalytic core of the ribosome where peptide bond formation
occurs (preferred for cognate tRNAs) competes with dissociation of the activated aminoacyl
tRNA (preferred for near-cognate tRNAs). (c) Kinetic proofreading during DNA
polymerization [1]. An incoming dNTP (blue oval) forms base-paring interactions with the
tempate strand (solid blue line) in the active site of DNA polymerase (red oval). The
incoming dNTP is incorporated into the nascent strand (dashed blue line) through
irreversible phosphodiester bond formation resulting in release of pyrophosphate. Base-
pairing at the nascent 3' end of DNA is then inspected a second time as additional productive
rounds of dNTP incorporation (preferred for a matched dNMP) compete with cleavage of
the nascent phosphodiester bond after relocalization to the polymerase editing site (preferred
for a mismatched dNMP), resulting in dissociation of dNMP (blue rectangle). (d) A distinct,
non-obligatory kinetic proofreading scheme employed during splicing and protein
translocation [8, 9, 16, 17, 39]. Unbound substrate (SU) binds the enzyme, forming an
enzyme substrate complex (SB). From the enzyme–substrate complex, conversion to a new
on-pathway intermediate (P) competes with an energy-dependent branch that results in
substrate rejection (SR). However, if NTP hydrolysis occurs after the productive step then
hydrolysis results in a new productive conformation (P'). (e) Kinetic proofreading during
exon ligation [14]. At exon ligation, the lariat intermediate 3' splice site binds the
spliceosome (blue oval) in a catalytic conformation. In this catalytic conformation, ligation
of the exons (yellow rectangles) (preferred for optimal splice sites) competes with ATP
Semlow and Jonathan P. Staley Page 19
Trends Biochem Sci. Author manuscript; available in PMC 2013 August 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
hydrolysis by Prp22, resulting in rejection of the 3' splice site (preferred for suboptimal
splice sites). ATP hydrolysis by Prp22 after exon ligation results in productive mRNA
release [29, 30]. (f) Kinetic proofreading during protein targeting to the translocation
machinery [10]. During protein targeting, a nascent signal peptide-ribosome complex is
recognized by GTP-bound signal recognition particle (SRP, blue oval), which forms a
complex with GTP-bound SRP receptor (SR, pink oval). At the translocon (red ovals),
productive loading of the nascent peptide cargo into the translocation machinery (preferred
for correct cargoes) competes with GTP hydrolysis by the SRP-SR complex, which results
in dissociation of the cargo-SRP-SR complex (preferred for incorrect cargoes). GTP
hydrolysis by SRP and SR after engagement of the cargo with translocation apparatus results
in productive recycling of SRP and SR.
Semlow and Jonathan P. Staley Page 20
Trends Biochem Sci. Author manuscript; available in PMC 2013 August 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure I (Box 1).
Splicing involves two sequential transesterification reactions. (a) The reactive groups in
each reaction are specified by splice site consensus sequences, shown for metazoa and
budding yeast [88]. (b) In the first step of splicing, known as 5' splice site cleavage, the 2'
hydroxyl of a conserved branch site adenosine attacks the 5' splice site phosphate forming a
branched, lariat intermediate and free 5' exon. In the second step, the 3' hydroxyl of the
cleaved 5' exon attacks the 3' splice site phosphate, ligating the exons and excising the lariat
intron. N, any nucleotide; R, purine; Y, pyrimidine.
Semlow and Jonathan P. Staley Page 21
Trends Biochem Sci. Author manuscript; available in PMC 2013 August 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure I (Box 3).
A three-state equilibrium model rationalizes genetic suppressors of substrate mutations. (a)
In the model, a population of spliceosomes (blue) assembled on an optimal substrate
equilibrates between 5' splice site cleavage (I) and exon ligation (II) conformations as well
as an intermediate conformation (i). Note: free energies of each state are arbitrarily set to the
same level. (b) The model implies that a mutation that impairs exon ligation destabilizes the
exon ligation conformation relative to the 5' splice site cleavage and intermediate
conformations, resulting in sequestration of the spliceosomes in these alternative
conformations. (c and d) In the model, the exon ligation defect shown in (b) is suppressed by
second-site mutations that repopulate the exon ligation conformation by destabilizing either
the 5' splice site cleavage conformation (c) or the intermediate conformation (d), relative to
the exon ligation conformation. Note that in all panels, destabilization of a particular state is
illustrated as underlying changes in equilibria, but stabilization of alternative states would
result in similar changes in equilibria. G, Gibbs free energy; in each panel the reaction
coordinate proceeds from left to right.
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